Deep vein thrombosis (DVT) is a vascular condition marked by the development of blood clots within the deep veins, commonly occurring in the legs. This medical ailment carries a significant risk as these clots have the potential to dislodge and traverse the circulatory system, reaching vital organs such as the lungs and precipitating a life-threatening condition called pulmonary embolism. The onset of DVT is frequently associated with diminished or sluggish blood flow, often stemming from prolonged periods of inactivity, recent surgical procedures, or underlying medical conditions affecting clotting mechanisms. Those with a familial predisposition to DVT, individuals who smoke, are overweight, or use hormonal medications like birth control pills may face an elevated risk. Recognizable symptoms of DVT encompass pain, swelling, and redness in the affected leg, though some instances may manifest without apparent signs. Timely diagnosis and intervention are imperative to avert complications, with treatment protocols typically involving anticoagulant medications and modifications to lifestyle.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Preservation of Skeletal Muscle Mass During GLP 1 Receptor Agonist Mediated Weight Loss Clinical Determinants Risk Stratification and Evidence Based Mitigation Strategies
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : A Unique Case of Infective Endocarditis: Staphylococcus lugdunensis Infective Endocarditis Presenting as Embolic Occipital Stroke Due to Posterior Mitral Leaflet Perforation
Nuha Hasnain, Royal Preston Hospital, United Kingdom
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation